medicine makers

Mubadala Bio, Eli Lilly lead UAE dealmaking spree in healthcare

The UAE has embraced GLP-1 weight-loss drugs and was an early launch market for Eli Lilly’s Mounjaro injector pen following its FDA approval

Peter Dazeley/Getty Images

Eli Lilly's Foundayo weight loss pills and Mounjaro injection pen will be packaged in the UAE by Mubadala Bio

Mubadala Bio, the life sciences arm of Abu Dhabi’s sovereign wealth fund, signed a deal with Eli Lilly to localize packaging and logistics for the U.S. pharmaceutical company’s blockbuster GLP-1 obesity and diabetes treatments.

The agreement, announced at...